The Pittsburgh Pirates are making a strategic move to bolster their pitching staff, but is this a calculated gamble or a desperate measure?
In a development that's sure to pique the interest of baseball fans, pitcher José Urquidy and the Pittsburgh Pirates have reportedly reached an agreement on a $1.5 million, one-year contract. This news, confirmed by a source close to the negotiations speaking to The Associated Press, signals a new chapter for the right-handed hurler. The deal, however, is contingent upon Urquidy successfully passing a physical examination.
Urquidy, a seasoned 30-year-old pitcher, brings valuable depth to a Pirates rotation that already boasts the impressive talent of NL Cy Young Award winner Paul Skenes. His addition also offers the team considerable roster flexibility, as he can be assigned to the minor leagues if needed. This is a crucial aspect for any team looking to navigate a long season effectively.
But here's where it gets a bit more complex. Urquidy's recent history includes Tommy John surgery on June 5, 2024, an injury he sustained while with the Houston Astros. He then signed a $1 million, one-year deal with the Detroit Tigers last March and made his return to the major leagues on September 14th. In his limited appearances last year, he pitched 2 1/3 innings across two relief outings, posting a 7.71 ERA. This comeback performance, while showing resilience, also raises questions about his current form.
Over his six-year major league career, Urquidy has demonstrated flashes of brilliance. He holds a respectable 27-16 record with a 4.00 ERA in 70 starts and 11 relief appearances for both the Astros (from 2019-23) and the Tigers. It's worth noting that in 2024, he also spent time on the injured list due to a forearm strain before undergoing his surgery. His postseason track record is also noteworthy, with a 4.08 ERA in 15 appearances, including eight starts.
And this is the part most people miss: While the contract value might seem modest, the potential impact of Urquidy's signing could be significant. The Pirates are clearly banking on his ability to rebound and contribute, especially given his past success. However, the lingering effects of his surgery and his recent struggles in limited action present a clear point of contention for some.
What do you think? Is this a smart, low-risk move by the Pirates to add experience and depth, or are they taking a significant gamble on a pitcher with a recent injury history? Share your thoughts in the comments below – we'd love to hear your take!
